Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Merck
Mallinckrodt
Argus Health
Teva
Colorcon
Covington

Generated: July 17, 2019

DrugPatentWatch Database Preview

Patent: 9,931,330

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,931,330
Title:Methods and devices for the treatment of ocular diseases in human subjects
Abstract: Methods and devices are provided for targeted non-surgical administration of a drug formulation to the suprachoroidal space (SCS) of the eye of a human subject for the treatment of a posterior ocular disorder or a choroidal malady. In one embodiment, the method comprises inserting a hollow microneedle into the eye at an insertion site and infusing a drug formulation through the inserted microneedle and into the suprachoroidal space of the eye, wherein the infused drug formulation flows within the suprachoroidal space away from the insertion site during the infusion. In one embodiment, the fluid drug formulation comprises drug nanoparticles or microparticles.
Inventor(s): Zarnitsyn; Vladimir (Atlanta, GA), Patel; Samirkumar (Atlanta, GA), White; Daniel (Suwanee, GA), Noronha; Glenn (Atlanta, GA), Burke; Brian (Cary, NC)
Assignee: CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA)
Application Number:15/673,073
Patent Claims:see list of patent claims

Details for Patent 9,931,330

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen ZINBRYTA daclizumab INJECTABLE;INJECTION 761029 001 2016-05-27 ➤ Sign Up CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA) ➤ Sign Up RX search
Regeneron Pharmaceuticals EYLEA aflibercept INJECTABLE; INJECTION 125387 001 2011-11-18 ➤ Sign Up CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA) ➤ Sign Up RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 002 2011-03-09 ➤ Sign Up CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA) ➤ Sign Up RX search
Human Genome Sciences Inc. BENLYSTA belimumab INJECTABLE; INJECTION 125370 001 2011-03-09 ➤ Sign Up CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA) ➤ Sign Up RX search
Bristol Myers Squibb ORENCIA abatacept INJECTABLE; IV (INFUSION) 125118 001 2005-12-23 ➤ Sign Up CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA) ➤ Sign Up RX search
Biogen Idec TYSABRI natalizumab VIAL; SINGLE-USE 125104 001 2004-11-23 ➤ Sign Up CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA) ➤ Sign Up RX search
Abbvie Inc HUMIRA adalimumab VIAL 125057 002 2002-12-31 ➤ Sign Up CLEARSIDE BIOMEDICAL, INC. (Alpharetta, GA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 9,931,330

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2014074823 May 15, 2014
United States of America 2015258120 Sep 17, 2015
United States of America 2016206628 Jul 21, 2016
United States of America 2016213662 Jul 28, 2016
United States of America 2017333416 Nov 23, 2017
United States of America 2018028516 Feb 01, 2018
United States of America 2018092897 Apr 05, 2018
Country Patent Number Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Chubb
US Army
Fish and Richardson
Covington
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.